Catalyst Wire Dossier Catalyst Wire Dossier

gD2t vaccine with MPL

glycoprotein D2t vaccine with MPL adjuvant · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for gD2t vaccine with MPL, covering 2016-09-07 to 2016-09-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease [Phase 3]

See pricing